PositiveID gets FDA clearance for iglucose technology

11/16/2011 | Health Data Management

The FDA has given PositiveID Corp. 510(k) clearance for its iglucose technology designed for patients with diabetes. The device enables patients to transmit blood glucose readings from a data-cable glucometer to a Web portal, where they can transmit information to family members and health care providers.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Exponent
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI